L&J Pipeline

L&J-HZ

Herpes Zoster, Chemical therapeutics

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-AD

Alzheimer’s Disease, Protein therapeutics targeting Amyloid-beta and p-Tau

AL04
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
AL07
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
AL08
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
AL09
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
AL10
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-PD

Parkinson’s Disease, Protein therapeutics

PD01
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
PD02
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA
PD03
  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

Next generation Fiber bioreactor

Single-Use Bioreactor

NeFi
  • R&D
  • Proof of Concept
  • Beta test
  • Commercialization